Key Stomach Antibodies

Stomach Cancer Antibodies

Stomach Antibodies

Stomach cancers are the fifteenth most diagnosed cancer in the United States, with about 7.4% of new cancer cases classified as stomach and contributing toward 3.4% of cancer deaths yearly. As of 2012, there were approximately 77,000 people living with stomach cancer in the United States. Those diagnosed with stomach cancer have a 5 year survival rates of only 29.3%. Over the last 10 years, the rate of new stomach cancer cases has fallen 1.5% per year, while the death rate has fallen 3% per year. Biocare Medical is proud to offer key stomach antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD,

Biocare Clone



Gall Bladder and Pancreas

Mucin 5AC


Biocare Clone

CA 19-9